ATG16L1 and liver disorder: To address whether autophagy inhibition and NEMO deletion act synergistically in the development of spontaneous liver disease, we generated mice lacking both ATG16L1 and NEMO in LPCs (ATG16L1LPC-KO NEMOLPC-KO) and compared them to the respective single knockouts.